We examined the peripheral blood and tumour DNA of KCF3 for methylation at other loci that are commonly methylated in breast cancer to assess whether the observed BRCA1 methylation was due to a propensity to methylate at a global level. This evidence concerns the gene BRCA1 and breast carcinoma.